The 20 Best Monoclonal Gammopathy of Undetermined Significance (MGUS) Doctors Near Me in San Francisco, CA

Gauri Kelekar is an Oncologist practicing medicine in San Francisco, California. She has been practicing medicine for over 18 years. Dr. Kelekar is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Hemochromatosis, Familial Colorectal Cancer, and Urothelial Cancer. Dr. Kelekar is board certified in Medical Oncology - Internal Medicine Hematology. Dr. Kelekar is currently accepting new patients.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Chung is currently accepting new patients.

Sandy Wong is a Hematologist practicing medicine in San Francisco, California. Dr. Wong is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

William Karlon is a Hematologist practicing medicine in San Francisco, California. Dr. Karlon is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma, Multiple Myeloma, and Gastric Lymphoma.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Martin is board certified in American Board Of Internal Medicine, Hematology. Dr. Martin is currently accepting new patients.

Dr. Shagun Arora is a hematologist-oncologist who specializes in caring for patients with malignant and classical (cancerous and noncancerous) blood disorders. She treats patients with diverse hematologic conditions in both categories. Her focus is monoclonal gammopathies, or conditions in which the blood contains abnormal proteins, including MGUS (monoclonal gammopathy of undetermined significance) and multiple myeloma, along with anemias. Arora's goal is to provide compassionate, supportive care that takes the whole person into consideration, while helping patients fight cancer. She considers it a privilege to be part of the lives of cancer patients and their families. In addition to patient care, she is passionate about medical education, working closely with training physicians who are pursuing fellowships in hematology and oncology. Arora is the medical director of the Infusion Center at UCSF's Parnassus campus. Arora completed her residency at Michigan State University, followed by a fellowship at MedStar Washington Hospital Center and MedStar Georgetown University Hospital, where she served as chief fellow. She is a member of several professional associations, including the American Society of Hematology, American Society of Clinical Oncology, Society of Hematologic Oncology and International Myeloma Society. In her free time, Arora enjoys international travel, yoga retreats and hiking to view the gorgeous vistas of San Francisco. Dr. Arora is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Arora is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Hematology. Dr. Arora is currently accepting new patients.

Robert Vazquez is a primary care provider, practicing in Family Medicine in San Francisco, California. Dr. Vazquez is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Low Sodium Level, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension. Dr. Vazquez is board certified in Family Medicine - Board Certified. Dr. Vazquez is currently accepting new patients.

Dr. Elad Ziv is a primary care doctor and a specialist in internal medicine. Ziv's research focuses on the genetic epidemiology (how inherited factors play a role in disease) of breast cancer and other age-related diseases. He also studies groups of mixed ethnicity to understand the relationship between environmental and genetic risk factors in explaining differences in cancer incidence. Ziv earned his medical degree and completed a residency in internal medicine at UCSF. He completed a fellowship in internal medicine at the San Francisco Veterans Affairs Health Care System and later the UCSF general internal medicine research fellowship. Dr. Ziv is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Multiple Myeloma, Asthma, Cerebral Amyloid Angiopathy, and Osteotomy. Dr. Ziv is board certified in American Board Of Internal Medicine, Internal Medicine. Dr. Ziv is currently accepting new patients.

Radhika Ramanan is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Ramanan is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her clinical expertise encompasses Essential Thrombocythemia, Maturity Onset Diabetes of the Young, Chronic Cough, and Type 2 Diabetes (T2D). Dr. Ramanan is board certified in American Board Of Internal Medicine, Internal Medicine. Dr. Ramanan is currently accepting new patients.

Dr. Nicole Appelle is a specialist in internal medicine who provides primary care. Appelle earned her medical degree and a master's degree in public health at George Washington University. She completed a residency in internal medicine at UCSF. Appelle is active in teaching medical students and interns in UCSF’s primary care clinics. Dr. Appelle is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Chronic Cough, Vertigo, Multisystem Inflammatory Syndrome in Children (MIS-C), and COVID-19. Dr. Appelle is board certified in American Board Of Internal Medicine, Internal Medicine. Dr. Appelle is currently accepting new patients.

Caroline Behler is a Hematologist practicing medicine in San Francisco, California. Dr. Behler is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 72 other conditions, according to our data. Her clinical expertise encompasses Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Bone Marrow Aspiration, and Gamma Knife Radiosurgery.

Don Ng is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Jaundice, Type 1 Diabetes (T1D), Meniere Disease, and Familial Hypertension.

Ajai Chari is an Oncologist practicing medicine in San Francisco, California. Dr. Chari is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wolf is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Medicine, Internal Medicine. Dr. Wolf is currently accepting new patients.

Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sayre is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Sayre is currently accepting new patients.

Dr. Michael Pourdehnad is a hematologist-oncologist who specializes in cancers that originate in blood-forming tissues or immune system cells. He also has expertise in noncancerous blood disorders. Pourdehnad is a physician-scientist, a medical doctor who devotes much of his time to research. In addition to treating patients, he is dedicated to developing novel therapies for cancer patients with especially challenging cases. In this capacity, he works with the biotechnology company Celgene to translate research discoveries into new treatments for blood cancers. After earning his medical degree from the Chicago Medical School at Rosalind Franklin University School of Medicine and Science, Pourdehnad completed a residency in internal medicine at Icahn School of Medicine at Mount Sinai, where he served as chief resident. He then completed a fellowship in adult hematologic malignancies and blood and marrow transplantation at UCSF. Dr. Pourdehnad is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and B-Cell Lymphoma. Dr. Pourdehnad is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Pourdehnad is currently accepting new patients.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.

Dr. Anupama Kumar is a hematologist-oncologist who specializes in caring for patients with multiple myeloma and other blood cancers. She also cares for patients who are undergoing treatments that include stem cell transplant, chemotherapy and cell therapies while in the hospital. In research, Kumar leads clinical trials evaluating new treatments for patients with multiple myeloma. Kumar earned her medical degree at Tufts University, where she also completed a residency in internal medicine. She completed a fellowship in hematology-oncology at University of California, San Diego, where she received specialized training in multiple myeloma and bone marrow transplant. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her clinical expertise encompasses Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. Dr. Kumar is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology, American Board Of Internal Medicine/Hematology, Hematology, and American Board Of Internal Medicine, Internal Medicine. Dr. Kumar is currently accepting new patients.

Dr. Karin Gaensler is a specialist in cancers of the blood who has a special interest in gene therapy. She is currently working to develop novel approaches for treating blood disorders caused by a specific gene mutation. Gaensler earned her medical degree from Harvard Medical School. She then went on to complete her residency in internal medicine and a fellowship in hematology and oncology at UCSF. Gaensler has received numerous awards, including a fellowship from the American Cancer Society, a fellowship from the Howard Hughes Medical Institute and a physician-scientist award from the National Institutes of Health. Dr. Gaensler is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Richter Syndrome, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gaensler is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology, American Board Of Internal Medicine/Hematology, Hematology, and American Board Of Internal Medicine, Internal Medicine. Dr. Gaensler is currently accepting new patients.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kaplan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Kaplan is currently accepting new patients.